Cargando…

Whole genome sequencing in pharmacogenomics

Pharmacogenomics aims to shed light on the role of genes and genomic variants in clinical treatment response. Although, several drug–gene relationships are characterized to date, many challenges still remain toward the application of pharmacogenomics in the clinic; clinical guidelines for pharmacoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsila, Theodora, Patrinos, George P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374451/
https://www.ncbi.nlm.nih.gov/pubmed/25859217
http://dx.doi.org/10.3389/fphar.2015.00061
_version_ 1782363491791798272
author Katsila, Theodora
Patrinos, George P.
author_facet Katsila, Theodora
Patrinos, George P.
author_sort Katsila, Theodora
collection PubMed
description Pharmacogenomics aims to shed light on the role of genes and genomic variants in clinical treatment response. Although, several drug–gene relationships are characterized to date, many challenges still remain toward the application of pharmacogenomics in the clinic; clinical guidelines for pharmacogenomic testing are still in their infancy, whereas the emerging high throughput genotyping technologies produce a tsunami of new findings. Herein, the potential of whole genome sequencing on pharmacogenomics research and clinical application are highlighted.
format Online
Article
Text
id pubmed-4374451
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-43744512015-04-09 Whole genome sequencing in pharmacogenomics Katsila, Theodora Patrinos, George P. Front Pharmacol Pharmacology Pharmacogenomics aims to shed light on the role of genes and genomic variants in clinical treatment response. Although, several drug–gene relationships are characterized to date, many challenges still remain toward the application of pharmacogenomics in the clinic; clinical guidelines for pharmacogenomic testing are still in their infancy, whereas the emerging high throughput genotyping technologies produce a tsunami of new findings. Herein, the potential of whole genome sequencing on pharmacogenomics research and clinical application are highlighted. Frontiers Media S.A. 2015-03-26 /pmc/articles/PMC4374451/ /pubmed/25859217 http://dx.doi.org/10.3389/fphar.2015.00061 Text en Copyright © 2015 Katsila and Patrinos. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Katsila, Theodora
Patrinos, George P.
Whole genome sequencing in pharmacogenomics
title Whole genome sequencing in pharmacogenomics
title_full Whole genome sequencing in pharmacogenomics
title_fullStr Whole genome sequencing in pharmacogenomics
title_full_unstemmed Whole genome sequencing in pharmacogenomics
title_short Whole genome sequencing in pharmacogenomics
title_sort whole genome sequencing in pharmacogenomics
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374451/
https://www.ncbi.nlm.nih.gov/pubmed/25859217
http://dx.doi.org/10.3389/fphar.2015.00061
work_keys_str_mv AT katsilatheodora wholegenomesequencinginpharmacogenomics
AT patrinosgeorgep wholegenomesequencinginpharmacogenomics